Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Period end update

13 Oct 2011 07:00

RNS Number : 0892Q
e2v technologies PLC
13 October 2011
 



 

13 October 2011

 

e2v technologies plc

 

Period end update

 

e2v technologies plc, the specialist provider of technology solutions for high performance systems, is today providing this period end update for the six months ended 30 September 2011.

 

Current Year trading and outlook

 

Group trading for the first half is expected to be in line with management's expectations and ahead of the comparable period in the previous year. Underlying revenue grew by over 16%, with reported revenue growth of 9%. The difference largely reflects one off revenues of £6m.

 

The broader macro economic environment remains of concern and there are some signs of softening demand.

 

We continue to make good progress in executing our strategic plan and our outlook for the full year remains unchanged.

 

RF Power Solutions

 

The RF Power Solutions Division has three key applications: radiotherapy, electronic countermeasures and industrial processing.

 

- Strong growth over the comparable period in radiotherapy reflects steady OEM demand.

- As anticipated, European demand for electronic countermeasures (ECM) continues to be lower. We have secured an order for microwave power modules from a European OEM and are also making good progress with two US ECM programmes.

- In industrial processing systems, agreement has been reached for the first commercial field trial installation of our ProWave™ vermiculite processing system, which is due to be installed shortly. We have made good progress on our development programmes and have recently received a further order for an RF generator to support research into a new potential application in the mining sector.

- The remaining product lines in the division, which serve predominantly commercial and industrial markets, continue to perform well relative to the prior year and steadily on a sequential basis.

 

 

 

High Performance Imaging Solutions

 

The three key applications of this division are: machine vision, space imaging and scientific imaging.

 

- The machine vision sector delivered comparable underlying performance with the prior year, although this has shown some recent softness.

- Space imaging has delivered significant growth over the comparable period, reflecting the achievement of milestones on established programmes and progress on new projects. We have received an order for a focal array subsystem for a Korean land based telescope and have been selected to provide the camera for a ground based space science application in Brazil.

- Scientific imaging is also showing good growth arising from stronger end user demand.

- The remaining product lines in the division continue to show good underlying growth.

 

Hi-rel Semiconductor Solutions

 

This division addresses two main sectors: Semiconductor Lifecycle Management (SLiM™) and aerospace and defence semiconductors.

 

- The SLiM™ programme continues to benefit from the successful delivery within its existing programmes and a further four new defence programmes in Europe and the US have been added in the period, as well as the extension of the Raytheon F15 contract to cover further product lines. We also secured our first customer contract to provide extended product availability in collaboration with Maxim Semiconductors Inc.

- For the remaining product lines in the division we have seen improved demand for test and assembly services in Europe and the US compared to the prior year.

 

Order Book

 

Our total order book as at 30 September 2011 was £146m (30 September 2010 £167m), whilst our order book for delivery in the coming 12 months as at 30 September 2011 was £120m (30 September 2010 £147m). The reduction in the order book for delivery in the coming 12 months reflects a £7m reduction in the level of 'one-off' orders and the cycle of multiyear radiotherapy orders of £9m. We are also seeing a change in mix, as European defence activity (reduced by £2m) has been replaced with more commercial and industrial business with shorter order cycles.

 

 

 

Net Borrowings

 

Net borrowings at 30 September 2011 increased from 30 June 2011 by £4m to £32m, with operational cash performance in line with our expectations.

 

The group's new £80m revolving banking facility became effective 27 July 2011 and expires on 27 July 2015. As at 30 September 2011 the group had available £41m of undrawn committed borrowings from the facility.

 

The group remains in a sound financial position.

 

 

 

Keith Attwood, Chief Executive, said:

 

"The group has performed strongly in the first half. The changing order book profile reflects the anticipated change in the mix of our businesses.

 

The broader macro economic environment remains of concern and there are some signs of softening demand.

 

We continue to make good progress in executing our strategic plan. We are securing early orders for our industrial processing systems business and repositioning ourselves in the value chain for key applications such as space imaging and electronic counter measures.

 

Our outlook for the full year remains unchanged."

 

 

 

Further enquiries:

 

e2v technologies plc

Tel: +44 (0)1245 493 493

Keith Attwood, Chief Executive

Charles Hindson, Group Finance Director

Website: www.e2v.com

Pelham Bell Pottinger

Tel: +44 (0)20 7861 3232

Archie Berens

Clare Gilbey

 

 

Notes to editors

 

 

1. Net borrowings exclude capitalised borrowing costs.

 

2. All financial information included in this release is sourced from management accounts.

 

3. Statements made in this announcement that look forward in time or that express management's beliefs, expectations or estimates regarding future occurrences are "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements reflect the Group's current expectations concerning future events and actual results may differ materially from current expectations or historical results.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMMMMGNZGGMZM
Date   Source Headline
6th Apr 20105:10 pmRNSHolding(s) in Company
1st Apr 20107:00 amRNSUpdate on Restructuring
29th Mar 20103:10 pmRNSHolding(s) in Company
22nd Mar 20104:35 pmRNSPrice Monitoring Extension
19th Mar 20104:37 pmRNSPrice Monitoring Extension
11th Mar 20104:08 pmRNSTotal Voting Rights
8th Mar 20104:25 pmRNSDirector/PDMR Shareholding
5th Mar 20102:55 pmRNSDirector/PDMR Shareholding
1st Mar 20107:00 amRNSUpdate on Restructuring
17th Feb 201011:15 amRNSTotal Voting Rights
2nd Feb 20107:00 amRNSInterim Management Statement
22nd Jan 20102:15 pmRNSHolding(s) in Company
19th Jan 201010:01 amRNSTotal Voting Rights
18th Dec 20093:55 pmRNSHolding(s) in Company
16th Dec 20092:31 pmRNSNOTIFICATION OF MAJOR INTERESTS IN SHARES
15th Dec 20094:25 pmRNSDirector/PDMR Shareholding
10th Dec 20094:27 pmRNSTotal Voting Rights
9th Dec 20095:33 pmRNSHolding(s) in Company
9th Dec 20095:32 pmRNSHolding(s) in Company
9th Dec 20095:29 pmRNSHolding(s) in Company
9th Dec 20095:25 pmRNSHolding(s) in Company
9th Dec 20095:25 pmRNSHolding(s) in Company
8th Dec 20095:32 pmRNSHolding(s) in Company
8th Dec 20095:26 pmRNSHolding(s) in Company
8th Dec 200910:03 amRNSResults of Rump Placing
8th Dec 20097:00 amRNSResults of Rights Issue
4th Dec 20092:26 pmBUSDisclosure of Short Position
2nd Dec 20093:23 pmRNSNotification of Transactions of Directors
2nd Dec 20091:58 pmBUSDisclosure of Short Position
27th Nov 200911:04 amRNSNotification of Transaction by Directors
25th Nov 20093:45 pmRNSNotification of Major Interests in Shares
25th Nov 20093:43 pmRNSNotification of Major Interests in Shares
25th Nov 20093:42 pmRNSNotification of Major Interests in Shares
25th Nov 20093:39 pmRNSNotification of Major Interests in Shares
25th Nov 20093:35 pmRNSNotification of Major Interests in Shares
20th Nov 20094:40 pmRNSSecond Price Monitoring Extn
20th Nov 20094:35 pmRNSPrice Monitoring Extension
20th Nov 200910:33 amRNSResults of General Meeting
10th Nov 20091:53 pmRNSTotal Voting Rights
6th Nov 20091:12 pmRNSProspectus Clarification
5th Nov 20094:20 pmRNSNotification of Major Interests in Shares
4th Nov 20094:41 pmRNSNotification of Major Interests in Shares
2nd Nov 20094:45 pmRNSPublication of Prospectus
2nd Nov 20093:39 pmRNSNotification of Major Interests in Shares
29th Oct 20094:40 pmRNSSecond Price Monitoring Extn
29th Oct 20094:35 pmRNSPrice Monitoring Extension
29th Oct 20097:10 amRNSInterim Results
29th Oct 20097:10 amRNSFirm Placing and Rights Issue
9th Oct 20097:00 amRNSPeriod End Update
7th Oct 200911:51 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.